 | • レポートコード：B-GIR08C0353 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール • 産業分類：Chemical & Material |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、API（医薬品有効成分）中間体の世界市場について調べ、まとめました。種類別セグメントは、バイオテクノロジー中間体、化学中間体等、用途別セグメントは、腫瘍学、糖尿病、内分泌学、心血管疾患、CNS・神経学的疾患等に区分しました。API（医薬品有効成分）中間体の世界市場概観、企業動向、企業別API（医薬品有効成分）中間体シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・API（医薬品有効成分）中間体の市場概観 ・API（医薬品有効成分）中間体の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・API（医薬品有効成分）中間体の企業別販売動向、市場シェア、市場集中度、競争動向 ・API（医薬品有効成分）中間体の世界市場規模 ・API（医薬品有効成分）中間体の北米市場分析（アメリカ、カナダ、メキシコ等） ・API（医薬品有効成分）中間体のアメリカ市場規模推移 ・API（医薬品有効成分）中間体のカナダ市場規模推移 ・API（医薬品有効成分）中間体のメキシコ市場規模推移 ・API（医薬品有効成分）中間体のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・API（医薬品有効成分）中間体のドイツ市場規模推移 ・API（医薬品有効成分）中間体のイギリス市場規模推移 ・API（医薬品有効成分）中間体のロシア市場規模推移 ・API（医薬品有効成分）中間体のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・API（医薬品有効成分）中間体の日本市場規模推移 ・API（医薬品有効成分）中間体の中国市場規模推移 ・API（医薬品有効成分）中間体の韓国市場規模推移 ・API（医薬品有効成分）中間体のインド市場規模推移 ・API（医薬品有効成分）中間体の東南アジア市場規模推移 ・API（医薬品有効成分）中間体の南米市場分析（ブラジル、アルゼンチン等） ・API（医薬品有効成分）中間体の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・API（医薬品有効成分）中間体の種類別分析/販売量、売上、市場シェア（バイオテクノロジー中間体、化学中間体） ・API（医薬品有効成分）中間体の用途別分析/市場規模（腫瘍学、糖尿病、内分泌学、心血管疾患、CNS・神経学的疾患） ・API（医薬品有効成分）中間体の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・API（医薬品有効成分）中間体の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for API(Active Pharmaceutical Ingredient) Intermediate is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the API(Active Pharmaceutical Ingredient) Intermediate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Jigs Chemical
Sanofi Winthrop Industrie S.A.
Shandong Jiulong Fine Chemical Co., Ltd.
Hipharma Limited
AMPAC Fine Chemicals
BASF
Cambrex Corporation
A R Life Sciences Pvt. Ltd.
Dragon Hwa ChemPharm. Co., Ltd.
Ami Life Sciences Pvt. Ltd.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Biotech Intermediates
Chemical Intermediates
Market Segment by Applications, can be divided into
Oncology
Diabetes
Endocrinology
Cardiovascular Disease
CNS & Neurological Disorders
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe API(Active Pharmaceutical Ingredient) Intermediate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of API(Active Pharmaceutical Ingredient) Intermediate, with price, sales, revenue and global market share of API(Active Pharmaceutical Ingredient) Intermediate in 2017 and 2018.
Chapter 3, the API(Active Pharmaceutical Ingredient) Intermediate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the API(Active Pharmaceutical Ingredient) Intermediate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, API(Active Pharmaceutical Ingredient) Intermediate market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe API(Active Pharmaceutical Ingredient) Intermediate sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 API(Active Pharmaceutical Ingredient) Intermediate Introduction
1.2 Market Analysis by Type
1.2.1 Biotech Intermediates
1.2.2 Chemical Intermediates
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Diabetes
1.3.3 Endocrinology
1.3.4 Cardiovascular Disease
1.3.5 CNS & Neurological Disorders
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Jigs Chemical
2.1.1 Business Overview
2.1.2 API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi Winthrop Industrie S.A.
2.2.1 Business Overview
2.2.2 API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Shandong Jiulong Fine Chemical Co., Ltd.
2.3.1 Business Overview
2.3.2 API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Hipharma Limited
2.4.1 Business Overview
2.4.2 API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 AMPAC Fine Chemicals
2.5.1 Business Overview
2.5.2 API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 BASF
2.6.1 Business Overview
2.6.2 API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 BASF API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Cambrex Corporation
2.7.1 Business Overview
2.7.2 API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 A R Life Sciences Pvt. Ltd.
2.8.1 Business Overview
2.8.2 API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Dragon Hwa ChemPharm. Co., Ltd.
2.9.1 Business Overview
2.9.2 API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Ami Life Sciences Pvt. Ltd.
2.10.1 Business Overview
2.10.2 API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Manufacturer (2017-2018)
3.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 API(Active Pharmaceutical Ingredient) Intermediate Manufacturer Market Share in 2018
3.3.2 Top 6 API(Active Pharmaceutical Ingredient) Intermediate Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global API(Active Pharmaceutical Ingredient) Intermediate Market Analysis by Regions
4.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Market Share by Regions
4.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Regions (2014-2019)
4.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue and Market Share by Regions (2014-2019)
4.2 North America API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
4.3 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
4.5 South America API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
5 North America API(Active Pharmaceutical Ingredient) Intermediate by Country
5.1 North America API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Market Share by Country
5.1.1 North America API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Country (2014-2019)
5.1.2 North America API(Active Pharmaceutical Ingredient) Intermediate Revenue and Market Share by Country (2014-2019)
5.2 United States API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
5.3 Canada API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
5.4 Mexico API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
6 Europe API(Active Pharmaceutical Ingredient) Intermediate by Country
6.1 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Market Share by Country
6.1.1 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Country (2014-2019)
6.1.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue and Market Share by Country (2014-2019)
6.2 Germany API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
6.3 UK API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
6.4 France API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
6.5 Russia API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
6.6 Italy API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
7 Asia-Pacific API(Active Pharmaceutical Ingredient) Intermediate by Country
7.1 Asia-Pacific API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific API(Active Pharmaceutical Ingredient) Intermediate Revenue and Market Share by Country (2014-2019)
7.2 China API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
7.3 Japan API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
7.4 Korea API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
7.5 India API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
7.6 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
8 South America API(Active Pharmaceutical Ingredient) Intermediate by Country
8.1 South America API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Market Share by Country
8.1.1 South America API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Country (2014-2019)
8.1.2 South America API(Active Pharmaceutical Ingredient) Intermediate Revenue and Market Share by Country (2014-2019)
8.2 Brazil API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
8.3 Argentina API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
8.4 Colombia API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
9 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate by Countries
9.1 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
9.3 Turkey API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
9.4 Egypt API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
9.5 Nigeria API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
9.6 South Africa API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
10 Global API(Active Pharmaceutical Ingredient) Intermediate Market Segment by Type
10.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Type (2014-2019)
10.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue and Market Share by Type (2014-2019)
10.2 Biotech Intermediates Sales Growth and Price
10.2.1 Global Biotech Intermediates Sales Growth (2014-2019)
10.2.2 Global Biotech Intermediates Price (2014-2019)
10.3 Chemical Intermediates Sales Growth and Price
10.3.1 Global Chemical Intermediates Sales Growth (2014-2019)
10.3.2 Global Chemical Intermediates Price (2014-2019)
11 Global API(Active Pharmaceutical Ingredient) Intermediate Market Segment by Application
11.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2014-2019)
11.2 Oncology Sales Growth (2014-2019)
11.3 Diabetes Sales Growth (2014-2019)
11.4 Endocrinology Sales Growth (2014-2019)
11.5 Cardiovascular Disease Sales Growth (2014-2019)
11.6 CNS & Neurological Disorders Sales Growth (2014-2019)
12 API(Active Pharmaceutical Ingredient) Intermediate Market Forecast (2019-2024)
12.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Growth Rate (2019-2024)
12.2 API(Active Pharmaceutical Ingredient) Intermediate Market Forecast by Regions (2019-2024)
12.2.1 North America API(Active Pharmaceutical Ingredient) Intermediate Market Forecast (2019-2024)
12.2.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Market Forecast (2019-2024)
12.2.3 Asia-Pacific API(Active Pharmaceutical Ingredient) Intermediate Market Forecast (2019-2024)
12.2.4 South America API(Active Pharmaceutical Ingredient) Intermediate Market Forecast (2019-2024)
12.2.5 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Market Forecast (2019-2024)
12.3 API(Active Pharmaceutical Ingredient) Intermediate Market Forecast by Type (2019-2024)
12.3.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast by Type (2019-2024)
12.3.2 Global API(Active Pharmaceutical Ingredient) Intermediate Market Share Forecast by Type (2019-2024)
12.4 API(Active Pharmaceutical Ingredient) Intermediate Market Forecast by Application (2019-2024)
12.4.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast by Application (2019-2024)
12.4.2 Global API(Active Pharmaceutical Ingredient) Intermediate Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure API(Active Pharmaceutical Ingredient) Intermediate Picture
Table Product Specifications of API(Active Pharmaceutical Ingredient) Intermediate
Figure Global Sales Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Types in 2018
Table API(Active Pharmaceutical Ingredient) Intermediate Types for Major Manufacturers
Figure Biotech Intermediates Picture
Figure Chemical Intermediates Picture
Figure API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Applications in 2018
Figure Oncology Picture
Figure Diabetes Picture
Figure Endocrinology Picture
Figure Cardiovascular Disease Picture
Figure CNS & Neurological Disorders Picture
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure Canada API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure Germany API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure France API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure UK API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure Russia API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure Italy API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure China API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure Korea API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure India API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Growth Rate (2014-2024)
Table Jigs Chemical Basic Information, Manufacturing Base and Competitors
Table Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
Table Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Winthrop Industrie S.A. Basic Information, Manufacturing Base and Competitors
Table Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
Table Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Shandong Jiulong Fine Chemical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
Table Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Hipharma Limited Basic Information, Manufacturing Base and Competitors
Table Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
Table Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table AMPAC Fine Chemicals Basic Information, Manufacturing Base and Competitors
Table AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
Table AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table BASF Basic Information, Manufacturing Base and Competitors
Table BASF API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
Table BASF API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Cambrex Corporation Basic Information, Manufacturing Base and Competitors
Table Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
Table Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table A R Life Sciences Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
Table A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Dragon Hwa ChemPharm. Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
Table Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Ami Life Sciences Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Type and Applications
Table Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales by Manufacturer (2017-2018)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Manufacturer in 2017
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Manufacturer in 2018
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue by Manufacturer (2017-2018)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Manufacturer in 2017
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Manufacturer in 2018
Figure Top 3 API(Active Pharmaceutical Ingredient) Intermediate Manufacturer (Revenue) Market Share in 2018
Figure Top 6 API(Active Pharmaceutical Ingredient) Intermediate Manufacturer (Revenue) Market Share in 2018
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2014-2019)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales by Regions (2014-2019)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Regions (2014-2019)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue by Regions (2014-2019)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Regions in 2014
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Regions in 2018
Figure North America API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Asia-Pacific API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure South America API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure North America API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2014-2019)
Table North America API(Active Pharmaceutical Ingredient) Intermediate Sales by Countries (2014-2019)
Table North America API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Countries (2014-2019)
Figure North America API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Countries in 2014
Figure North America API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Countries in 2018
Table North America API(Active Pharmaceutical Ingredient) Intermediate Revenue by Countries (2014-2019)
Table North America API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries (2014-2019)
Figure North America API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries in 2014
Figure North America API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries in 2018
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Canada API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Mexico API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2014-2019)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Sales by Countries (2014-2019)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Countries (2014-2019)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue by Countries (2014-2019)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries in 2017
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries in 2018
Figure Germany API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure UK API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure France API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Russia API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Italy API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Asia-Pacific API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2014-2019)
Table Asia-Pacific API(Active Pharmaceutical Ingredient) Intermediate Sales by Countries (2014-2019)
Table Asia-Pacific API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Countries 2018
Table Asia-Pacific API(Active Pharmaceutical Ingredient) Intermediate Revenue by Countries (2014-2019)
Figure Asia-Pacific API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries 2018
Figure China API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Korea API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure India API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure South America API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2014-2019)
Table South America API(Active Pharmaceutical Ingredient) Intermediate Sales by Countries (2014-2019)
Table South America API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Countries (2014-2019)
Figure South America API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Countries in 2018
Table South America API(Active Pharmaceutical Ingredient) Intermediate Revenue by Countries (2014-2019)
Table South America API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries (2014-2019)
Figure South America API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries in 2018
Figure Brazil API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Argentina API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Colombia API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2014-2019)
Table Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Sales by Countries (2014-2019)
Table Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Countries in 2018
Table Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue by Countries (2014-2019)
Table Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries in 2014
Figure Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Countries in 2018
Figure Saudi Arabia API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure UAE API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Egypt API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure Nigeria API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Figure South Africa API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2014-2019)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales by Type (2014-2019)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Type (2014-2019)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue by Type (2014-2019)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Type (2014-2019)
Figure Global Biotech Intermediates Sales Growth (2014-2019)
Figure Global Biotech Intermediates Price (2014-2019)
Figure Global Chemical Intermediates Sales Growth (2014-2019)
Figure Global Chemical Intermediates Price (2014-2019)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales by Application (2014-2019)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Application (2014-2019)
Figure Global Diabetes Sales Growth (2014-2019)
Figure Global Endocrinology Sales Growth (2014-2019)
Figure Global Cardiovascular Disease Sales Growth (2014-2019)
Figure Global CNS & Neurological Disorders Sales Growth (2014-2019)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Growth Rate (2019-2024)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast by Regions (2019-2024)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Market Share Forecast by Regions (2019-2024)
Figure North America Sales API(Active Pharmaceutical Ingredient) Intermediate Market Forecast (2019-2024)
Figure Europe Sales API(Active Pharmaceutical Ingredient) Intermediate Market Forecast (2019-2024)
Figure Asia-Pacific Sales API(Active Pharmaceutical Ingredient) Intermediate Market Forecast (2019-2024)
Figure South America Sales API(Active Pharmaceutical Ingredient) Intermediate Market Forecast (2019-2024)
Figure Middle East and Africa Sales API(Active Pharmaceutical Ingredient) Intermediate Market Forecast (2019-2024)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast by Type (2019-2024)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Market Share Forecast by Type (2019-2024)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast by Application (2019-2024)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
小分子活性医薬成分の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Small Molecule Active Pharmaceutical Ingredient is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the S…- 世界のジェネリック医薬品有効成分市場2019 The global Generic Active Pharmaceutical Ingredients market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Generic Active Pharmaceutical Ingredients market status and forecast, categorizes the glo…
- 化学中間体市場：世界及び中国市場分析・予測（～2024年） Chemical Intermediates Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Chemical Intermediates industry with a focus on the Chinese market. The report provides key statistics on the market status of the Chemical Intermediates m…
- 高効力活性医薬品成分（API）市場：世界及び中国の市場分析・予測（～2024年） High Potency Active Pharmaceutical Ingredient Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global High Potency Active Pharmaceutical Ingredient industry with a focus on the Chinese market. The report provides key statistics on the…
- イオン交換樹脂中間体の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Ion Exchange Resin Intermediates is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Ion Exchange Res…